Quethera Overview

  • Founded
  • 2013

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $111M

Quethera General Information

Description

Developer of gene therapy technologies designed to improve the future treatment of common blinding eye diseases. The company's technologies focus on the development of therapies that reduce progressive visual loss in glaucoma and other conditions affecting the optic nerve, enabling patients to get efficient treatment for their eye diseases and recover faster.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • The Babraham Institute, Babraham Hall House
  • Babraham
  • Cambridge CB22 3AT
  • England, United Kingdom

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quethera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 10-Aug-2018 $111M 00000 00000 Completed Generating Revenue
3. Grant 07-Mar-2016 00000 00000 Completed Startup
2. Early Stage VC 07-Aug-2015 $625K $625K 00.000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Quethera’s complete valuation and funding history, request access »

Quethera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 00.000
To view Quethera’s complete cap table history, request access »

Quethera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of gene therapy technologies designed to improve the future treatment of common blinding eye diseases. The com
Biotechnology
Cambridge, United Kingdom
00000
0000 0000-00-00
000000&0 00000

000000

ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad mi
0000000000000
Alpharetta, GA
00 As of 0000
00000
000000000 00000

000000

eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia
0000000000000
Pasadena, CA
000 As of 0000
00.000
000000 - 000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Quethera Competitors (39)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Clearside Biomedical Formerly VC-backed Alpharetta, GA 00 00000 000000000 00000
000000000 00000000 Corporation Pasadena, CA 000 00.000 000000 - 000 00.000
0000 000000000000 Venture Capital-Backed London, United Kingdom 00 00000 0000000000 0 00000
0000000 Venture Capital-Backed Cambridge, United Kingdom 00 00.000 0000000000 0 00.000
0000000 0000000000 Formerly PE-Backed Cambridge, MA 000 0000 000000000 0000
You’re viewing 5 of 39 competitors. Get the full list »

Quethera Patents

Quethera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018248651-A1 Genetic construct for use in the treatment of neurodegenerative disorder or stroke Pending 05-Apr-2017 0000000000
CA-3058549-A1 Genetic construct for use in the treatment of neurodegenerative disorder or stroke Pending 05-Apr-2017 0000000000
ES-2881176-T3 Genetic construction for use in the treatment of neurodegenerative disorder or stroke Active 05-Apr-2017 0000000000
US-20200046850-A1 Genetic construct Pending 05-Apr-2017 0000000000
EP-3606546-B1 Genetic construct for use in the treatment of neurodegenerative disorder or stroke Active 05-Apr-2017 C12N15/86
To view Quethera’s complete patent history, request access »

Quethera Executive Team (2)

Name Title Board Seat Contact Info
Keith Martin Chief Scientific Officer
Peter Widdowson Ph.D Co-Founder, Board Member & Chief Executive Officer
To view Quethera’s complete executive team members history, request access »

Quethera Board Members (3)

Name Representing Role Since
Peter Widdowson Ph.D Self Co-Founder, Board Member & Chief Executive Officer 000 0000
You’re viewing 1 of 3 board members. Get the full list »

Quethera Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Babraham Bioscience Technologies Accelerator/Incubator 000 0000 000000 0
Cambridge Enterprise Venture Capital Minority 000 0000 000000 0
Midven Venture Capital Minority 000 0000 000000 0
Parkwalk Advisors Venture Capital Minority 000 0000 000000 0
UK Innovation & Science Seed Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »